UBS Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Sell |
1,993,158
-291,120
| -13% | -$361K | ﹤0.01% | 3646 |
|
|
2025
Q1 | $2.7M | Buy |
2,284,278
+798,263
| +54% | +$942K | ﹤0.01% | 3481 |
|
|
2024
Q4 | $2.72M | Buy |
1,486,015
+843,166
| +131% | +$1.54M | ﹤0.01% | 3468 |
|
|
2024
Q3 | $1.09M | Sell |
642,849
-186,285
| -22% | -$317K | ﹤0.01% | 3526 |
|
|
2024
Q2 | $1.14M | Buy |
829,134
+151,881
| +22% | +$208K | ﹤0.01% | 3298 |
|
|
2024
Q1 | $2.54M | Buy |
677,253
+643,359
| +1,898% | +$2.41M | ﹤0.01% | 2777 |
|
|
2023
Q4 | $333K | Buy |
33,894
+11,247
| +50% | +$110K | ﹤0.01% | 4266 |
|
|
2023
Q3 | $189K | Sell |
22,647
-207,435
| -90% | -$1.73M | ﹤0.01% | 4302 |
|
|
2023
Q2 | $3.06M | Buy |
230,082
+193,508
| +529% | +$2.57M | ﹤0.01% | 2313 |
|
|
2023
Q1 | $424K | Sell |
36,574
-16,261
| -31% | -$188K | ﹤0.01% | 3821 |
|
|
2022
Q4 | $432K | Sell |
52,835
-27,350
| -34% | -$224K | ﹤0.01% | 3816 |
|
|
2022
Q3 | $465K | Buy |
80,185
+40,554
| +102% | +$235K | ﹤0.01% | 3426 |
|
|
2022
Q2 | $175K | Sell |
39,631
-57,591
| -59% | -$254K | ﹤0.01% | 4047 |
|
|
2022
Q1 | $885K | Sell |
97,222
-2,760
| -3% | -$25.1K | ﹤0.01% | 3342 |
|
|
2021
Q4 | $2.05M | Sell |
99,982
-9,570
| -9% | -$196K | ﹤0.01% | 2858 |
|
|
2021
Q3 | $2.8M | Sell |
109,552
-45,756
| -29% | -$1.17M | ﹤0.01% | 2489 |
|
|
2021
Q2 | $5.43M | Buy |
155,308
+68,428
| +79% | +$2.39M | ﹤0.01% | 1935 |
|
|
2021
Q1 | $2.89M | Buy |
86,880
+3,996
| +5% | +$133K | ﹤0.01% | 2435 |
|
|
2020
Q4 | $2.15M | Buy |
82,884
+45,079
| +119% | +$1.17M | ﹤0.01% | 2581 |
|
|
2020
Q3 | $373K | Buy |
37,805
+3,165
| +9% | +$31.2K | ﹤0.01% | 3606 |
|
|
2020
Q2 | $119K | Sell |
34,640
-112,842
| -77% | -$388K | ﹤0.01% | 4350 |
|
|
2020
Q1 | $451K | Sell |
147,482
-1,013,463
| -87% | -$3.1M | ﹤0.01% | 3304 |
|
|
2019
Q4 | $5.97M | Sell |
1,160,945
-424,207
| -27% | -$2.18M | ﹤0.01% | 1882 |
|
|
2019
Q3 | $8.18M | Sell |
1,585,152
-64,858
| -4% | -$335K | ﹤0.01% | 1499 |
|
|
2019
Q2 | $9.98M | Buy |
1,650,010
+102,516
| +7% | +$620K | ﹤0.01% | 1383 |
|
|
2019
Q1 | $11.2M | Sell |
1,547,494
-371,679
| -19% | -$2.69M | ﹤0.01% | 1288 |
|
|
2018
Q4 | $14.2M | Buy |
1,919,173
+1,428,246
| +291% | +$10.6M | 0.01% | 1029 |
|
|
2018
Q3 | $2.66M | Buy |
490,927
+100,111
| +26% | +$542K | ﹤0.01% | 2391 |
|
|
2018
Q2 | $1.39M | Buy |
390,816
+89,090
| +30% | +$316K | ﹤0.01% | 2817 |
|
|
2018
Q1 | $619K | Buy |
301,726
+127,112
| +73% | +$261K | ﹤0.01% | 3344 |
|
|
2017
Q4 | $461K | Sell |
174,614
-100,687
| -37% | -$266K | ﹤0.01% | 3515 |
|
|
2017
Q3 | $1.45M | Buy |
275,301
+162,066
| +143% | +$851K | ﹤0.01% | 2724 |
|
|
2017
Q2 | $403K | Sell |
113,235
-266
| -0.2% | -$947 | ﹤0.01% | 3483 |
|
|
2017
Q1 | $586K | Sell |
113,501
-5,712,291
| -98% | -$29.5M | ﹤0.01% | 3183 |
|
|
2016
Q4 | $22.1M | Buy |
5,825,792
+5,745,024
| +7,113% | +$21.8M | 0.01% | 716 |
|
|
2016
Q3 | $724K | Sell |
80,768
-32,630
| -29% | -$292K | ﹤0.01% | 2918 |
|
|
2016
Q2 | $798K | Buy |
113,398
+105,880
| +1,408% | +$745K | ﹤0.01% | 2863 |
|
|
2016
Q1 | $64K | Sell |
7,518
-2,253
| -23% | -$19.2K | ﹤0.01% | 4524 |
|
|
2015
Q4 | $128K | Buy |
9,771
+3,556
| +57% | +$46.6K | ﹤0.01% | 4061 |
|
|
2015
Q3 | $22K | Sell |
6,215
-2,961
| -32% | -$10.5K | ﹤0.01% | 5372 |
|
|
2015
Q2 | $53K | Buy |
9,176
+5,976
| +187% | +$34.5K | ﹤0.01% | 4741 |
|
|
2015
Q1 | $19K | Buy |
3,200
+700
| +28% | +$4.16K | ﹤0.01% | 5421 |
|
|
2014
Q4 | $20K | Buy |
+2,500
| New | +$20K | ﹤0.01% | 5554 |
|